JSCAI 2022: The Year in Review
- PMID: 39129818
- PMCID: PMC11308507
- DOI: 10.1016/j.jscai.2023.100605
JSCAI 2022: The Year in Review
Keywords: congenital heart disease; coronary disease; peripheral vascular disease; structural heart disease.
References
-
- Kereiakes D.J., Hill J.M., Shlofmitz R.A., et al. Intravascular lithotripsy for treatment of severely calcified coronary lesions: 1-year results from the Disrupt CAD III study. J Soc Cardiovasc Angiogr Interv. 2022;1(1) - PubMed
-
- Tepe G., Brodmann M., Bachinsky W., et al. Intravascular lithotripsy for peripheral artery calcification: mid-term outcomes from the randomized Disrupt PAD III trial. J Soc Cardiovasc Angiogr Interv. 2022;1(4) - PubMed
-
- Ahmad Y., Petrie M.C., Jolicoeur E.M., et al. PCI in patients with heart failure: current evidence, impact of complete revascularization, and contemporary techniques to improve outcomes. J Soc Cardiovasc Angiogr Interv. 2022;1(2)
-
- Naidu S.S., Baran D.A., Jentzer J.C., et al. SCAI SHOCK Stage Classification Expert Consensus Update: a review and incorporation of validation studies: this statement was endorsed by the American College of Cardiology (ACC), American College of Emergency Physicians (ACEP), American Heart Association (AHA), European Society of Cardiology (ESC) Association for Acute Cardiovascular Care (ACVC), International Society for Heart and Lung Transplantation (ISHLT), Society of Critical Care Medicine (SCCM), and Society of Thoracic Surgeons (STS) in December 2021. J Soc Cardiovasc Angiogr Interv. 2022;1(1) - PubMed
Publication types
LinkOut - more resources
Full Text Sources
